Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Biomerica Inc. (Ticker: BMRA) is an innovative biotechnology firm focused on developing and manufacturing cutting-edge diagnostic solutions catering to both medical and food industries. The company specializes in proprietary testing methods aimed at metabolic diseases, gastrointestinal disorders, and food intolerances, positioning itself to significantly enhance healthcare outcomes and diagnostic precision. With a commitment to addressing unmet medical needs, Biomerica capitalizes on strategic research partnerships and advanced technology integration, facilitating growth in the dynamic diagnostics market. Its patient-centric strategy further underscores the potential for transformative improvements in global healthcare diagnostics, making it a compelling prospect for institutional investors.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$2.31
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended May 31, 2026 Reported Aug 27, 2026 | — | $-0.38 | — | — | — | $875.0K | — | 1D Pre-4.5% | On-Day+24.3% | 1D Post+1.9% |
Q ended Feb 28, 2026 Reported Apr 13, 2026 | — | $-0.43 | — | $-0.44 | — | $987.0K | — | 1D Pre-3.2% | On-Day-2.3% | 1D Post+1.0% |
Q ended Nov 30, 2025 Reported Jan 14, 2026 | $0.00 | |||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| $-0.45 |
| Miss |
| — |
| — |
| $1.2M |
| — |
| 1D Pre+1.1% |
| On-Day-0.4% |
| 1D Post-0.7% |
Q ended Aug 31, 2025 Reported Oct 14, 2025 | — | $0.00 | — | — | — | $1.4M | — | 1D Pre-1.1% | On-Day+2.9% | 1D Post-0.7% |